Archive for December, 2019

$JMDA is “One to Watch”

December 30, 2019

  • Focused on the development of digital communities, targeted marketing of branded digital content, and e-commerce opportunities
  • Operating through three strategic divisions to encompass its market strategies and objectives
  • 10-year growth plan includes a near-term rebranding strategy with addition of many new revenue streams to greatly increase Jerrick’s potential market value
  • Balanced portfolio of revenue streams will ensure institutional stability

Jerrick Media Holdings, Inc. (OTC: JMDA) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.

Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.

Vocal

Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.

Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.

In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.

Vocal for Brands

Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.

Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.

Growth Strategy

Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.

This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.

Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.

Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.

History & Management

Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.

Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.

Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.

Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.

For more information, visit the company’s website at https://Jerrick.media

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://nnw.fm/JMDA

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, December 30th, 2019 Uncategorized Comments Off on $JMDA is “One to Watch”

$TGODF Horizons ETFs Rebalances Marijuana-Focused Index ETF Suite

Canada NewsWire

TORONTO, Dec. 30, 2019

Horizons ETFs has completed its final marijuana ETFs rebalance of 2019

TORONTO, Dec. 30, 2019  –  Horizons ETFs Management (Canada) Inc. (“Horizons ETFs“) has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (“HMMJ”:TSX), the Horizons US Marijuana Index ETF (“HMUS”:NEO) and the Horizons Emerging Marijuana Growers Index ETF (“HMJR”:NEO).

HMMJ is the world’s first ETF offering direct exposure to North American-listed securities that have significant business activities in the marijuana industry. Amid contraction within the marijuana sector, seven constituents were removed from HMMJ’s portfolio:

Deletions

Company Name Ticker Exchange
Heritage Cannabis Holdings Corp CANN Canadian Securities Exchange
Emerald Health Therapeutics EMH TSX Venture Exchange
Eve & Co Inc EVE TSX Venture Exchange
Fsd Pharma Inc HUGE Canadian Securities Exchange
48North Cannabis Corp NRTH TSX Venture Exchange
Radient Technologies Inc RTI TSX Venture Exchange
Zenabis Global Inc ZENA Toronto Stock Exchange

 

HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. This index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry. The North American Marijuana Index selects from a current universe of companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bioproducts and other ancillary businesses related to the marijuana industry. Securities within HMMJ’s index generally have a market capitalization of greater than CAD $75 million.

The performance of the Marijuana sector in Q4 was quite disappointing. As a result, the market capitalization of a number of HMMJ’s holdings fell below their minimum inclusion threshold, leading to their removal from the index and the ETF,” said Steve Hawkins, President and CEO of Horizons ETFs. “Within HMMJ’s portfolio, this has resulted in the survival of the fittest: HMMJ’s holdings are now more concentrated on companies that are maintaining a strong position within the cannabis industry, despite difficult market conditions.”

Rebalancing of the North American Marijuana Index, and consequently HMMJ, occurs each calendar quarter. At that point, all stocks eligible for inclusion are generally re-weighted by their respective market capitalization. The holdings of HMMJ and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMMJ.

Performance Update as at December 20, 2019*

1 Month 3 Month 6 Months YTD 1 Year Annualized
Since Inception**
HMMJ -4.48% -34.28% -51.52% -34.71% -34.76% 0.73%
NAMMAR Index -5.77% -32.43% -51.08% -34.51% -34.55% -6.26%
TX60AR Index 0.58% 1.77% 4.58% 22.52% 23.95% 7.08%

 

* Source: Bloomberg, as at December 20, 2019. ** Since HMMJ’s inception on April 4, 2017.

The indicated rates of return are the historical annual compounded total returns, including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Additionally, index returns do not take into account management, operating or trading expenses that may be incurred in replicating the index. The rates of return above are not indicative of future returns. ETFs are not guaranteed, their values change frequently, and past performance may not be repeated. The indices are not directly investible.

HMUS REBALANCE

Launched in April 2019, HMUS is the world’s first U.S.-focused marijuana index ETF.

HMUS seeks to replicate, to the extent possible, the performance of the US Marijuana Companies Index, net of expenses. This index is designed to provide exposure to the performance of a basket of publicly-listed companies having significant business activities in, or significant exposure to, the marijuana or hemp industries in the United States. Constituents of this index are selected from Canadian and U.S. exchanges. While some securities may be listed on major North American exchanges, the majority of the securities currently trade on North American exchanges that include but are not limited to the Canadian Securities Exchange and the Aequitas NEO Exchange.

This rebalance resulted in the removal of seven companies:

Deletions

Company Name Ticker Exchange
Chemesis International Inc CSI Canadian Securities Exchange
Dixie Brands Inc DIXI Canadian Securities Exchange
4front Ventures Corp FFNT Canadian Securities Exchange
High Tide Inc HITI Canadian Securities Exchange
Rubicon Organics Inc ROMJ Canadian Securities Exchange
Sol Global Investments Corp SOL Canadian Securities Exchange
1933 Industries Inc TGIF Canadian Securities Exchange

 

“We continue to believe that the United States has the potential be the world’s largest cannabis market from an investment perspective,” said Mr. Hawkins. “Several instances of key federal and state-level legislation have signalled progress on greater cannabis liberalization in the country, including the SAFE Banking Act, the MORE Act, and the legalization of recreational cannabis in Illinois. We are optimistic about what’s in store for the United States’ cannabis sector in 2020.”

Rebalancing of the US Marijuana Companies Index, and consequently HMUS, occurs each calendar quarter. At that point, all stocks eligible for inclusion are generally re-weighted by their respective market capitalization. The holdings of HMUS and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMUS.

HMJR REBALANCE

HMJR seeks to replicate, to the extent possible, the performance of the Emerging Marijuana Growers Index, net of expenses. This index is designed to provide exposure to the performance of a basket of primarily North American publicly-listed small-capitalization companies primarily involved in the cultivation, production and/or distribution of marijuana.

HMJR invests in companies with market capitalizations generally between CAD $50 million and CAD $500 million. The ETF’s portfolio is 100% invested in marijuana producers and distributors, and it can have exposure to companies outside of North America.

The HMJR portfolio recently expanded to include the following eight constituents:

Additions

Company Name Ticker Exchange
Ayr Strategies Inc AYR.A Canadian Securities Exchange
C21 Investments Inc CXXI Canadian Securities Exchange
Ianthus Capital Holdings Inc IAN Canadian Securities Exchange
Medmen Enterprises Inc MMEN Canadian Securities Exchange
Cannaroyalty Corp OH Canadian Securities Exchange
Seach Medical Group Ltd SEMG Tel Aviv Stock Exchange
Sundial Growers Inc SNDL NASDAQ
Green Organic Dutchman Holdings TGOD Toronto Stock Exchange

 

The following 20 companies were removed from HMJR’s portfolio on this rebalance:

Deletions

Company Name Ticker Exchange
Choom Holdings Inc CHOO Canadian Securities Exchange
Creso Pharma Ltd CPH Australian Securities Exchange
Chemesis International Inc CSI Canadian Securities Exchange
Dixie Brands Inc DIXI Canadian Securities Exchange
Delta 9 Cannabis Inc DN Toronto Stock Exchange
Emerald Health Therapeutics EMH TSX Venture Exchange
Eve & Co Inc EVE TSX Venture Exchange
Exmceuticals Inc EXM Canadian Securities Exchange
FSD Pharma Inc HUGE Canadian Securities Exchange
Harvest One Cannabis Inc HVT TSX Venture Exchange
Integrated Cannabis Co Inc ICAN Canadian Securities Exchange
James E Wagner Cultivation Cor JWCA TSX Venture Exchange
Mjardin Group Inc MJAR Canadian Securities Exchange
Mgc Pharmaceuticals Ltd MXC Australian Securities Exchange
Ravenquest Biomed Inc RQB Canadian Securities Exchange
Sunniva Inc SNN Canadian Securities Exchange
Sproutly Canada Inc SPR Canadian Securities Exchange
Wildflower Brands Inc SUN Canadian Securities Exchange
THC Global Group Ltd THC Australian Securities Exchange
Westleaf Inc WL TSX Venture Exchange

 

Rebalancing of the Emerging Marijuana Growers Index, and consequently HMJR, occurs each calendar quarter. At that point, all stocks eligible for inclusion are generally re-weighted by their respective market capitalization. The holdings of HMJR and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMJR.

About Horizons ETFs Management (Canada) Inc. (www.HorizonsETFs.com)

Horizons ETFs Management (Canada) Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has approximately $10 billion of assets under management and 91 ETFs listed on major Canadian stock exchanges.

Commissions, management fees and expenses all may be associated with an investment in exchange traded products (the “Horizons Exchange Traded Products”) managed by Horizons ETFs Management (Canada) Inc. The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing.

There are risks associated with this product. HMUS is expected to invest in the Marijuana industry in certain U.S. states that have legalized marijuana for therapeutic or adult-use, which is currently illegal under U.S. federal law. HMUS will passively invest in companies involved in the marijuana industry in the U.S. where local state law regulates and permits such activities, as well as in companies involved in the Canadian legal Marijuana industry. HMUS will not be directly engaged in the manufacture, importation, possession, use, sale or distribution of marijuana in either Canada or the U.S. Please read the full risk disclosure in the prospectus before investing.

Monday, December 30th, 2019 Uncategorized Comments Off on $TGODF Horizons ETFs Rebalances Marijuana-Focused Index ETF Suite

$PBIO Zacks Small Cap Research Releases Updated Report

SOUTH EASTON, Mass., Dec. 30, 2019 — via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research (“Zacks SCR”) has released an updated research report in its on-going coverage on the Company.

Copies of the new Zacks SCR report can be obtained via the following link:

PBIO: Looking ahead to 2020

Any opinions, judgments, estimates, or forecasts regarding the Company’s historical or predicted performance or operations made by Zacks SCR are theirs alone and do not represent opinions, judgments, estimates, or forecasts of the Company or its management. The Company does not by its reference to the research prepared by Zacks SCR imply its endorsement or adoption of or concurrence with such information, conclusions, or recommendations.

About Zacks Small Cap Research
Zacks Small Cap Research (“Zacks SCR”) is a division of Zacks Investment Research. Zacks SCR coverage specifically looks to focus on small and micro-cap companies that are underfollowed or undervalued by Wall Street.  Our analysts seek to identify and report on these companies, bringing to investors a unique opportunity to gain insight on small cap investments that are believed to be undervalued and well-positioned for future growth.  Our goal is to produce high quality (institutional) research for the small cap portfolio.

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” estimates,” “predicts,” “projects,” “potential” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law. Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

Investor Contacts:
Richard T. Schumacher, President and CEO, (508) 230-1828 (T)
Jeffrey N. Peterson, Chairman of the Board, (650) 812-8121 (T)

For more information about PBI and this press release, please click on the following website link:

http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.

Monday, December 30th, 2019 Uncategorized Comments Off on $PBIO Zacks Small Cap Research Releases Updated Report

$POAI Building AI-driven Ovarian Cancer Model to Predict Tumor Drug Response

Predictive Oncology (NASDAQ: POAI), through its subsidiary Helomics, is sequencing ovarian cancers as part of a CancerQuest 2020 project, building the largest ovarian multi-omic database in the world. An article discussing the company reads, “As part of its CancerQuest 2020 project, Predictive Oncology, through Helomics, recently signed a collaborative agreement with UPMC-Magee to establish a data- and artificial-intelligence-driven approach to treating ovarian cancer. Based on the agreement, the partnership is designed to validate the significant value of using AI-powered decision-making for identifying specific treatments on specific genotypes to predict clinical outcomes for ovarian cancer patients. . . . Helomics has also begun sequencing retrospective ovarian cancer cases from the UPMC-Magee collaboration (http://nnw.fm/peQC8). As part of the sequencing process, Helomics is analyzing the mutations in the tumor (genome) and the expression of genes (transcriptome) in order to build a comprehensive multi-omic picture of the tumor. That information can then be brought together with Helomics’ data set of drug-response profiles to build an AI-driven predictive model of ovarian cancer.”

To view the full article, visit http://nnw.fm/uZD3r

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through five segments (domestic, international, clinical, CRO and DCHIP), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary, precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered, proprietary bioinformatics platform (D-CHIP) to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, December 30th, 2019 Uncategorized Comments Off on $POAI Building AI-driven Ovarian Cancer Model to Predict Tumor Drug Response

$LXRP Awards Options

Kelowna, British Columbia – December 30, 2019 – Lexaria Bioscience Corp. (OTC:LXRP) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that on December 30, 2019 it issued stock options to an employee to purchase up to 60,000 common shares of the Company at an exercise price of US$0.43 for a period of five years, vested over a three year term.

Lexaria also announces that it has cancelled 550,000 options with an exercise price of US$0.10 per common share which were held by an insider of the Company.

About Lexaria

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter (https://twitter.com/lexariacorp)

and on Facebook https://www.facebook.com/lexariabioscience/

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Chris Bunka, CEO

(250) 765-6424

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional patent protection will be realized or that patent achievements will deliver material results. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance the Company will be capable of developing, marketing, licensing, or selling edible products containing cannabinoids, nicotine or any other active ingredient. There is no assurance that any planned corporate activity, scientific research or study, business venture, letter of intent, technology licensing pursuit, patent application or allowance, consumer study, or any initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease.

Monday, December 30th, 2019 Uncategorized Comments Off on $LXRP Awards Options

$SGLB Transforming Blossoming 3D-Printing Sector with Next Gen Quality-Assurance Software

Sigma Labs (NASDAQ: SGLB), a developer of quality-assurance software for the commercial 3D-printing industry, has developed a method of overcoming quality-assurance obstacles that thwart 3D-metal printing from becoming fully integrated into modern manufacturing lines. An article discussing the company reads, “The company is about to revolutionize commercial 3D-printing metal by enabling nondestructive quality assurance during the production process. Sigma Labs’ proprietary PrintRite3D software is a real-time, computer-aided inspection (‘CAI’) technology long sought by 3D-printing companies to lower costs and increase yields. PrintRite3D(R) represents a breakthrough in the 3D-quality inspection sphere because it is the only known real-time, in-process, quality-assurance software for the commercial 3D-metal-printing industry. . . . 3D printing, also called additive manufacturing, is a technology that allows producers to transform a 3D-digital model of an object into a physical one by adding material rather than subtracting it, hence the additive in the name. The resulting 3D objects are made in a digitally controlled and operated process by depositing minuscule layers of material onto a substrate layer.”

To view the full article, visit http://nnw.fm/1f7Pi

About Sigma Labs Inc.

Sigma Labs (NASDAQ: SGLB) is a leading provider of quality-assurance software to the commercial, 3D-printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided inspection (CAI) solutions known as PrintRite3D for 3D advanced-manufacturing technologies. Sigma Labs’ advanced, computer-aided, software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production and uniquely allowing errors to be corrected in real time. For more information, visit the company’s website at www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, December 30th, 2019 Uncategorized Comments Off on $SGLB Transforming Blossoming 3D-Printing Sector with Next Gen Quality-Assurance Software

$SGLB Demonstrates Latest PrintRite3D(R) Version at Major Global 3D-Printing Conference

Developer of quality-assurance software for the commercial 3D-printing industry Sigma Labs Inc. (NASDAQ: SGLB) recently demonstrated the latest version of its proprietary technology PrintRite3D(R) in collaboration with Materialise NV at the Formnext 2019 conference held in Frankfurt, Germany. A recent article discussing the company reads, “At the event, Sigma Labs’ chief technology officer Darren Beckett presented on ‘The Integration of PrintRite3D Melt Pool Monitoring Software with Materialise’s Machine Control Platform (MCP) for Advanced Process Control.’ The presentation showcased version 5.2 of the software, which features several software enhancements including the automated anomaly detection with Z connectivity that identifies thermal defects, which propagate across multiple layers and enhanced data-trend analysis and customizable thresholding that enable automatic alerts. These new functionalities should further strengthen the capabilities of additive manufacturing for serial production.”

To view the full article, visit http://nnw.fm/wM325

About Sigma Labs Inc.

Sigma Labs (NASDAQ: SGLB) is a leading provider of quality-assurance software to the commercial 3D-printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided inspection (CAI) solutions known as PrintRite3D for 3D advanced manufacturing technologies. Sigma Labs’ advanced, computer-aided, software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production, uniquely allowing errors to be corrected in real time. For more information, visit the company’s website at www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, December 27th, 2019 Uncategorized Comments Off on $SGLB Demonstrates Latest PrintRite3D(R) Version at Major Global 3D-Printing Conference

$LXRP USDA Extends Hemp Rules Comment Period By 30 Days

December 27, 2019

Players in the hemp sector could finally heave a sigh of relief after the U.S. Department of Agriculture released the much-awaited interim final rule on hemp this October. Published in the Federal Register on October 31, the rule established a domestic hemp production program authorized by the Agricultural Improvement Act of 2018, also known as the Farm Bill.

When the 2018 Farm Bill legalized industrial hemp and its extracts last year, the market for hemp and hemp-derived CBD exploded. By the end of 2018, the CBD market was worth at least $8 billion, and it’s expected to hit $20 billion by 2026. However, there was one drawback to such swift growth.

Regulatory authorities were stuck playing catch up, resulting in an unregulated industry teeming with thousands of untested products each claiming untold medical benefits, which was very unsafe for consumers. On top of that, essential service providers avoided working with hemp growers fearing repercussions from law enforcement.

Unfortunately, the USDA’s interim final rule wasn’t the Hail Mary many thought it would be. Complaints abound that the regulations laid out by the USDA for the budding hemp sector are too stringent, and they may bring the industry down before it can truly soar.

When the interim rule was published, the USDA granted stakeholders a comment period to offer their own opinions on the new hemp rules. In a bid to get more feedback, the agency has announced that the comment period on its interim final hemp rule has been extended by 30 days to January 29.

Scott Propheter, Vice President of Agronomy and Outreach at Criticality, a North Carolina based hemp and CBD producer, urges growers to take advantage of this extension and reach out to their state agriculture departments and members of Congress.

“The USDA is going to be working directly with state regulators on this, so the more growers are involved with their state departments of agriculture the better off we’re going to be,” he says.

He adds that state regulators are on the growers’ side, even if it doesn’t always seem so. The interim final rule on hemp puts the burden on both growers and the state, and regulators want to work closely with growers to find the best solution to an increasingly complex issue.

Ben Marcus co-owns Sheepscot General Store and Farm, a farm and retailer in Whitefield, and he agreed stating that his state regulators have been invaluable in sharing insights.

“They’re not just going to test people’s crops to make sure everybody’s in compliance, but they’re helping us to understand the tumultuous political process that this is going through right now.”

He encourages farmers all across the country to reach out to their state lawmakers. “We don’t work for them, they work for us, so use them.”

This extension of the comments period is likely to be welcome news to hemp industry players like Dama Financial and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) who see it as an opportunity for a lot more people to voice their concerns regarding the interim hemp rules.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

Friday, December 27th, 2019 Uncategorized Comments Off on $LXRP USDA Extends Hemp Rules Comment Period By 30 Days

$TGODF Cannabis Weekly Round-up: Aurora Gives Executive the Boot

During the past trading week (December 23 to 27), a prominent C-level executive was dismissed from his role at one of Canada’s largest cannabis companies.

Another Canadian cannabis firm saw a massive value drop on its announcement of a US$25 million registered direct offering, which will dilute the value of its existing shares.

Here’s a closer look at some of the biggest cannabis news over the week.

Aurora Cannabis dips during volatile week

In a sudden move, one of Aurora Cannabis’ (NYSE:ACB,TSX:ACB) more front-facing executives, Cam Battley, “stepped down” from his role as chief corporate officer, the company announced, ending his three year stint with Aurora.

A news release sent out last Saturday (December 21) was followed by a 6.4 percent drop in Aurora’s share value in Toronto on Monday (December 23).

The slump continued across the week, and the company opened at C$2.55 on Friday (December 27), its lowest point year-to-date.

While Aurora did not mention the specific reason for Battley’s shift, the company confirmed he gained a role as a member of the board of directors for privately held medical cannabis company MedReleaf Australia in November. Aura holds a 10 percent stake in this venture, as well as 50 percent voting rights.

In the statement, Aurora CEO Terry Booth congratulated Battley on his work with the company. “We are grateful for Cam’s leadership and passion over his many years with Aurora. I am sure Cam will be successful as he moves on to tackle Australia,” he said.

Things took another dramatic turn, however, when it was revealed that Battley was asked to step down from his role. In an emailed statement to the Canadian Press, it wasn’t made clear why Battley was let go, but Aurora did say the move was a part of its effort to restructure its leadership strategy.

The rocky week continued for Aurora after The Coca-Cola Company (NYSE:KO) ended speculation that it plans to enter the cannabis market.

After the release of a since-deleted YouTube video in which a user claimed the firm was looking to launch a line of cannabidiol-infused Coca-Cola drinks in Canada, the company said it has no plans to throw its hat into the cannabis ring.

“These rumors are untrue,“ Coca-Cola said in an emailed statement to Bloomberg News. “As we have stated many times, we have no plans to enter the CBD market.”

Back in 2018, a BNN Bloomberg report indicated that the Georgia-based drink maker was in “serious talks” with the Canadian cannabis firm to create cannabis-infused beverages, which caused a boost for Aurora

HEXO faces losses following share sale

Beleaguered cannabis company HEXO (NYSE:HEXO,TSX:HEXO) stumbled again this week after its US-listed shares dropped over 20 percent following the announcement of an agreement with institutional investors for the purchase and sale of almost 15 million of its common shares for US$25 million.

The Quebec-based cannabis company told investors on Thursday (December 26) that it plans to use the proceeds as working capital to fund its research and development operations, among other corporate purposes.

HEXO took a hit earlier this month with the release of its fiscal Q1 2020 results. It reported a net loss of C$62.4 million in the quarter, a 10.1 percent rise from the C$56.7 million reported in Q4 2019.

The company blamed a slow retail opening in key Canadian provinces for its disappointing results.

During an earnings call with investors and analysts, HEXO CEO Sebastien St-Louis said, “We don’t believe that the retail channel will be substantially built until the end of 2021 or part way through 2022. The illicit market channel will continue to thrive until retail access is brought to the majority of Canadians.”

Year-to-date, HEXO has fallen 57.9 percent in New York.

Market updates

On Tuesday (December 24), Origin House (CSE:OH,OTCQX:ORHOF) reminded shareholders of the Friday (December 27) deadline for voting on its acquisition by Cresco Labs (CSE:CL,OTCQX:CRLBF).

According to Origin House, an overwhelming majority — over 99 percent — of shareholders have already voted in favor of the transaction.

The announcement came after Cresco Labs confirmed the all-stock deal — once called the “largest-ever public company acquisition” in the US cannabis industry — will move forward on reduced terms with a non-brokered financing on the part of Origin House of over 9.7 million of its own shares. The new deal is supposed to help reinforce the balance sheet of the combined company, Cresco said in a statement.

The Green Organic Dutchman (TSX:TGOD,OTCQX:TGODF) closed its previously announced senior secured credit facility of up to C$42.7 million with Maynbridge Capital.

This comes during a trying time for the firm, which has scrambled to acquire capital. It got its hands on C$103 million in funding in November, only to scrap that deal two weeks later in favor of an offering agreement with Canaccord Genuity to raise C$22 million in gross proceeds.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Friday, December 27th, 2019 Uncategorized Comments Off on $TGODF Cannabis Weekly Round-up: Aurora Gives Executive the Boot

$SRAX Extends Expiration for BIGtoken Special Dividend to Dec 31, 2020

LOS ANGELES, Dec. 27, 2019 — SRAX, Inc. (Nasdaq: SRAX), a digital marketing and consumer data management technology company, has extended the expiration time for its special dividend right from December 31, 2019 to on or before 5:00 p.m., ET, on December 31, 2020.

Special Dividend, Dividend Right and Expiration Date

On September 17, 2018, the company issued a non-transferable right (“Dividend Right”) to receive at no charge a special dividend to holders of the company’s Class A common stock as well as certain holders of the company’s common stock equivalents. If and when declared, the Special Dividend consisting of such number and designation of the SRAX subsidiary BIGtoken, Inc.’s securities (“Special Dividend”) as determined by the company’s management at their sole discretion. The Dividend Right was set to expire on or before 5:00 p.m., ET, on December 31, 2019, unless extended by the Company (the “Expiration Time”). The Dividend Right will now expire if the Special Dividend is not declared on or before 5:00 p.m., ET, on December 31, 2020, unless further extended by the company.

The Special Dividend will be an analog security, i.e., not digital, and not a cryptocurrency, and the Special Dividend is expected to be a fractional non-voting security that, if and when issued, is expected to only participate in a portion of the financial performance of the BIGtoken platform.

Transfer Agent and Questions
For further questions regarding the Dividend Right, please contact the information agent at:

Transfer Online, Inc.™
512 SE Salmon St., Portland, OR 97214
+1 (503) 227-2950

Advisement
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.  Any term or condition contained in this press release, other than the claim that the Special Dividend will be analog and not digital, nor a cryptocurrency, is made based on the Company’s information, beliefs and anticipated development as of the date hereof.  The Company reserves that right to alter, modify, or change any other term herein based on future developments.

THE DECLARATION AND ISSUANCE OF THE SPECIAL DIVIDEND IS SUBJECT TO SUBSTANTIAL STATE AND FEDERAL REGULATION AS WELL AS THE POSSIBLE APPROVAL OF ANY EXCHANGE ON WHICH THE SHARES OF SOCIAL REALITY, INC. ARE TRADED.  ACCORDINGLY, WE CAUTION ANY HOLDER THAT THE SPECIAL DIVIDEND MAY NEVER BE DECLARED AND EVEN IF DECLARED, ULTIMATELY MAY NOT BE ISSUE.  THE HOLDER IS CAUTIONED TO NOT PLACE ANY RELIANCE UPON ITS ABILITY TO RECEIVE THE SPECIAL DIVIDEND IN THE FUTURE OR THE VALUE, IF ANY, THAT SUCH SPECIAL DIVIDEND MAY HAVE.

About SRAX
SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency, and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury, and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information on SRAX, visit www.srax.com.

About BIGtoken
BIGtoken, built by SRAX (NASDAQ: SRAX), is a consumer data management and distribution system. BIG is the first consumer-managed data marketplace where people can own and earn from their data. Through a transparent platform and consumer reward system, BIG offers consumers choice, transparency, and compensation for their data. Participating consumers earn rewards, and developers are able to build pro-consumer online experiences on top of the BIG platform. The system also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. For more information on BIGtoken, visit www.bigtoken.com.

Safe Harbor Statement
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words or expressions such as “anticipate,” “plan,” “will,” “intend,” “believe” or “expect'” or variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to expectations of our ability to increase our revenues, satisfy our obligations as they become due, report profitable operations and other risks and uncertainties as set forth in our Annual Report on Form 10-K for the year ended December 31, 2018, and our subsequent Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of SRAX and are difficult to predict. SRAX undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Friday, December 27th, 2019 Uncategorized Comments Off on $SRAX Extends Expiration for BIGtoken Special Dividend to Dec 31, 2020

$POAI Subsidiary’s Revolutionary Technology Enables Faster, More Accurate Tumor Identification

Data and artificial-intelligence (“AI”) driven, discovery-services company Predictive Oncology’s (NASDAQ: POAI) subsidiary TumorGenesis is developing quicker, less costly and more precise Patient Derived Xenograft (“PDx”) cancer models that better mimic the patient’s tumor. An article discussing the company reads, “TumorGenesis excels not only in identifying cancer cell lines but also in developing a medium necessary to grow cancer-cell colonies in a way that will not compromise their integrity — a consideration critical to the success of every cancer research. This revolutionary technology is creating an unparalleled competitive advantage for the parent company POAI, as it allows for faster and more accurate identification of tumors and the development of patient-specific treatment options. The company expects this revolutionary product to hit the market by the end of the year. . . . What is unique with TumorGenesis’ state-of-the-art approach to cancer research is that the company has already developed 25 validated, ovarian, cancer-cell types that mature into uncompromised tumor colonies not only in vitro but in rats and mice too — a formidable accomplishment as 15 out of 25 cell lines represent around 90% of all ovarian cancers discovered so far, including those most virulent and deadly.”

To view the full article, visit http://nnw.fm/CmD6B

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through five segments (domestic, international, clinical, CRO and DCHIP), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary, precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered, proprietary bioinformatics platform (D- CHIP) to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, December 26th, 2019 Uncategorized Comments Off on $POAI Subsidiary’s Revolutionary Technology Enables Faster, More Accurate Tumor Identification

$SRAX Favorably Positioned for Growth in Q4

December 3, 2019

  • SRAX holds competitive advantage as big brands seek solutions that legacy partners cannot address
  • Thousands joining BIGtoken platform daily with minimal marketing
  • Four nonprofits, three CPG brands added to opt-in platform, increasing usage, reputation and reach

SRAX Inc. (NASDAQ: SRAX) sits at the epicenter of consumer privacy and data ownership. Leveraging its BIGtoken platform, the Company has made it possible for consumers to own their own data and get paid for the release of that data while also creating specific data sets around highly valuable verticals. On November 13, 2019, SRAX hosted a conference call for executives to share Q3 earnings and a forward look into Q4 with investors (http://nnw.fm/72m3W).

“Consumers are awakening to their online privacy and value exchange that exists for their personal information,” George Stella, SRAX’s vice president for brands and shopper marketing, stated in a news release. “Privacy regulations are happening fast now with California or CCPA and other states taking hold, and these conditions are creating a competitive advantage for us because big brands are moving to find solutions that their legacy partners can no longer address.”

These changes, both in the United States and globally, along with the ability to provide brands with a complete view of a consumer’s journey, have given SRAX a distinct competitive advantage. The BIGtoken platform is the means by which consumers are enabled to own their own data. As of the call, subscriber base has grown to 16.3 million users with minimal marketing spending, positioning the Company as a leader in this space. The platform continues to see anywhere from 3,000 to 10,000 people join a day.

The platform has expanded globally and is listed in the top 100 applications in the App Store and Google Play. The opt-in, user-controlled data set has proven to be the perfect remedy to GDPR’s impact. In addition to the acceptance it has seen in the 28 member countries of the European Union, the platform has also seen significant growth in Brazil, Indonesia, Italy and the Philippines. SRAX is strongly positioned to conduct research worldwide for big brand global organizations.

During Q3, BIGtoken added the ability for consumers to donate their earnings to the American Heart Association, HealthCorps, The ALS Association and Keep a Child Alive. Users from more than 20 countries have already donated to these nonprofits. During this same time, the Company’s BIG Rewards program, an exclusive offer for consumers to redeem earnings at specific retailers, added Procter & Gamble, Kraft and Sun-Maid. These three major CPG brands evaluated the platform and saw it as an innovative way to gain quality data.

The BIG Rewards program creates additional revenue for the organization while also bringing new users to the BIGtoken platform. The program allows companies access to a user base that has high privacy settings on social media, a consumer group that brands might typically have a hard time reaching.

A second platform, SRAX IR, is focused on helping CEOs and CFOs identify, manage and communicate with their investor base in groundbreaking ways. A few of the platform’s features include the ability to track shareholders’ behaviors and trends over time, get real-time market data including your company’s level two data, and engage shareholders across marketing channels including social media, email, and programmatic. Subscribing companies can utilize SRAX to turn their shareholder base into a revenue stream.

Additional verticals allow SRAX to sell access to specific data sets to an increasing number of brands. The two platforms are being leveraged to build crossover into the verticals. “We spent the past few quarters integrating our platforms and realigning the sales process and are now well positioned for growth,” added SRAX CEO Christopher Miglino. “Looking ahead, we expect to accelerate revenue by engaging with big brands across all three of our platforms.”

As the demand for data insights increase, SRAX is confident in growth prospects across its verticals. During Q3, the Company raised $5.5 million through a registered direct offering. As of September 30, 2019, SRAX reported being debt free, having cash and cash equivalents on hand of $2.8 million, and having approximately 13.9 million shares outstanding compared to 9.9 million in September 2018.

The best way to understand the BIGtoken platform is to join and discover how surveys are conducted and consumers are given control over personal data.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, December 26th, 2019 Uncategorized Comments Off on $SRAX Favorably Positioned for Growth in Q4

$OGI Ships First Wave of Vaporizer Offerings

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, today announced release of the first of its ‘Cannabis 2.0’ products, including Trailblazer Spark, Flicker and Glow 510-thread Torch vape cartridges.  According to the update, shipments of the custom-designed cartridges were sent to Manitoba, Saskatchewan, Ontario, New Brunswick and Nova Scotia, starting December 17, from the Company’s Moncton production campus. “As a company, bringing the next-generation of cannabis products to market without delay was important to us. We are proud to support access to tested, quality derivative-based products that we expect to help strengthen the regulated market and benefit those who prefer those product types over others,” Organigram CEO Greg Engel said in the news release. “Being one of the first licensed producers in the country ready to provide vape products, following the expiration of Health Canada’s 60-day notification period, illustrates that degree of focus and commitment. It speaks to an extraordinary effort by our internal teams who helped bring the Trailblazer Torch to market.”

To view the full press release, visit http://cnw.fm/aC42I

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).  For more information, visit the company’s website at www.Organigram.ca.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Monday, December 23rd, 2019 Uncategorized Comments Off on $OGI Ships First Wave of Vaporizer Offerings

$GGBXF Congress Gives the FDA Funds to Oversee Hemp CBD

December 23, 2019

For the past few years, cannabidiol (CBD) has held the medical, health and wellness and sports communities enthralled. If you’ve been paying any attention to the news, chances are you’ve heard of it too. The compound was barely known three years ago, but now it’s gracing the top of search lists and experts claim the hemp/CBD market will be worth billions by 2026.

Cannabidiol’s main draw lies in its medicinal properties. It is a potent and versatile medicine, with users claiming it gave them relief from a variety of medical conditions including high blood pressure, anxiety, and depression. Last year, the U.S. Food and Drug Administration approved Epidiolex, a CBD-based drug to treat seizures in two rare pediatric disorders Lennox-Gastaut Syndrome and Dravet Syndrome.

However, CBD was an exception from the norm. Usually, it takes the FDA at least two years to draw up a regulatory framework for a new product that’s about to hit the shelves. The CBD industry, on the other hand, ballooned so quickly and at such massive rates that regulatory authorities were left playing catch up.

This left the sector in an awkward position. Although the 2018 Farm Bill had made it legal to grow and sell hemp and products made from hemp extracts, the industry was massively unregulated. In just a year, the market was filled with thousands of untested and unregulated products. On top of that, hemp farmers were denied essential services such as banking and insurance as the providers shied away from the sector.

In a bid to reign in the industry and provide it with a sense of direction, federal lawmakers have granted the FDA and the U.S. Department of Agriculture (USDA) $2 million for research, policy evaluation, market surveillance and issuance of an enforcement discretion policy.

According to the legislation, the FDA has 60 days to report the Agency’s progress towards obtaining and analyzing data that will help determine a policy of enforcement discretion, and how CBD products that fall squarely under the legal definition of hemp will be evaluated for use in products.

It has also been granted 180 days to perform a sampling study of CBD products that are currently in the market to determine the extent to which the products are mislabeled or adulterated.

The Natural Product Association (NPA), based in Washington, D.C, argues that the legislation doesn’t do enough to protect consumers.

“While providing funding for testing is a positive first step, unfortunately, today’s action falls short of what is needed to protect consumers. The future of the U.S. hemp industry and the farmers and producers who provide it are directly tied to smart regulations for CBD, which includes the FDA establishing a safe level of consumption so consumers are protected,” says NPA President and CEO, Daniel Fabricant.

“We are concerned that if Congress fails to act next year then we could see another vaping-like public health crisis.”

Experts think that cannabidiol companies, such as Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) had hoped for more but this FDA funding is a beginning on the long journey towards a regulated and stable CBD market.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Monday, December 23rd, 2019 Uncategorized Comments Off on $GGBXF Congress Gives the FDA Funds to Oversee Hemp CBD

$LXRP Drug-Delivery Platform Continues Reaching New Milestones

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently announced further advances in its proprietary, oral, drug-delivery platform: DehydraTECH(TM). An article discussing the company reads, “Lexaria’s early pilot-stage human trials with tetrahydrocannabinol (THC) delivery show its newest formulation of DehydraTECH-enhanced edibles begin providing cannabinoid effectiveness in less than 10 minutes, which is about twice as fast as traditional DehydraTECH and four to six times faster than generic industry formulations, according to a company news release (http://cnw.fm/2owxO). . . . Lexaria has been developing DehydraTECH solutions as alternatives to smoked or vaped drug delivery over the course of the past three years, establishing a means whereby edible consumption of certain substances can provide results at rates comparable to inhaled substances and faster than ingested substances in general.”

To view the full article, visit http://cnw.fm/vOF1Y

About Lexaria Bioscience Corp.

Lexaria Bioscience is a global innovator in drug-delivery platforms. The company’s patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Friday, December 20th, 2019 Uncategorized Comments Off on $LXRP Drug-Delivery Platform Continues Reaching New Milestones

$OGI Are You Watching These Canadian Pot Stocks?

In the past six months, negative news has become the norm talking about marijuana stocks. While this may be the present state of the industry, it seems as though there are some pot stocks that are definitely worth watching. These few companies are making big moves that should help them move into the future of the industry. With all eyes set on the next few years, innovation is leading the charge right now.

One of the key things to note is that the value in the cannabis industry may not be where most expect to find it. Because the industry covers such a broad scope, the real value is hiding amidst the sub-sectors of the market. These areas include money transport, realty services, extraction businesses and more. With so many to choose from, these two key pot stocks are definitely ones to watch moving forward.

Marijuana Stock To Watch: A Cannabis Cultivator

OrganiGram Holdings (OGI Stock Report) is one of the largest pot stocks in the market. The company was able to push out as much as CA$80 million in revenue for the year ending results. With this, the company also posted around CA$9.5 million in losses for 2019. This number may sound like a lot, but considering the losses of CA$22 million in the previous year, it becomes smaller. The company has been working to up its production of the substance by producing 16 new rooms for the growth of the substance.

This is all being done in its Moncton, New Brunswick facility. With these new growing areas, the company should be able to push out as much as 90,000 kilograms of cannabis when operating at peak capacity. This is quite a lot, and will only payout if the company has a valid source of demand for the product. Only time will tell how well OrganiGram is able to fair with growing concerns of over-production in the Canadian area of the cannabis market.

Marijuana Stocks To Watch: Focusing On A Canadian Cannabis Company

Aleafia Health (ALEAF Stock Report) (ALEF)is another one of the big Canadian pot stocks to watch. The company saw its medicinal cannabis sales rise by as much as 43% from the previous quarter of the same year. With eyes set on being one of the largest sellers of cannabis in Canada, the company still definitely has a long way to go. Many believe that Aleafia Health is positioned to be one of the top players in the Canadian market as its current state of business presents some new and interesting opportunities.

The company has consistently been able to execute its operational practices in the form of new outdoor growing areas. The company states that it expects high levels of cultivation to be one of the leading reasons behind its success in the near future. The hopes are high that Aleafia Health can keep up its momentum as the future continues to weed out the big guys from the smaller pot stocks.

Friday, December 20th, 2019 Uncategorized Comments Off on $OGI Are You Watching These Canadian Pot Stocks?

$YGYI Announces Payment Timing of Regular Monthly Dividend for Series “D” Cumulative Redeemable Perpetual Preferred Stock

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company, today announced the timing for the payment of its declared regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (NASDAQ: YGYIP) for December 2019. According to the update, the dividend will be payable on January 15, 2020 to holders of record as of December 31, 2019. The dividend will be paid in cash.

To view the full press release, visit http://cnw.fm/GqK90

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI, YGYIP), is a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For investor information, please visit www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Friday, December 20th, 2019 Uncategorized Comments Off on $YGYI Announces Payment Timing of Regular Monthly Dividend for Series “D” Cumulative Redeemable Perpetual Preferred Stock

$SRAX Focusing on Privacy, Data Ownership as It Builds Valuable Opt-In Consumer Data Set

December 20, 2019

  • SRAX offers consumers ability to receive payment for release of their data
  • Company’s emphasis is on protection of individuals’ personal information, a critical element in today’s data world
  • SRAX’s BIGtoken platform provides advertisers access to verified consumer data

SRAX Inc. (NASDAQ: SRAX) is a digital marketing and data management technology company providing marketers and consumers tools to unlock the value of data. Privacy and data ownership are the Company’s emphasis. Headquartered in Los Angeles, SRAX focuses on offering consumers the ability to own their data and receive payment for the release of it. SRAX is in the process of building the most valuable opted-in consumer data set in the world.

The protection of individuals’ personal information is a major issue today. Recently, the Consumer Online Privacy Rights Act (COPRA) was officially introduced in the U.S. Senate. The strict proposal would give U.S. citizens the same privacy rights that citizens of the European Union have under the General Data Protection Regulation (GDPR) and has serious implications for United States companies.

“With COPRA in place, consumers would have the right to request which data companies are collecting and ask for that data to be deleted or corrected,” noted an article written by the BIGtoken team (http://nnw.fm/EKq2P). “Companies would also need to get explicit consent from anyone before collecting and sharing their data.”

SRAX is at the vanguard of developing a consumer-managed data marketplace and giving consumers control over their information – a power previously unavailable to consumers. The SRAX BIGtoken platform allows consumers to own and monetize their data. This control is significant because today’s consumers expect to receive compensation for releasing their data, while at the same time keeping that data safe, secure and private.

BIGtoken essentially enables consumers to control which pieces of their own data are for sale and which companies can buy them. In addition, BIGtoken provides advertisers access to verified consumer data to better reach and serve audiences. With privacy issues and concerns regarding social media channels such as Facebook, Twitter, Snapchat, LinkedIn and others on everyone’s radar, SRAX offers a premier solution via BIGtoken as the platform creates a secure and transparent environment for consumers. The opportunity to earn money from the release of data has resulted in BIGtoken racking up more than 16 million users around the world thus far, with that number growing every day.

Once consumers grant BIGtoken access to their information, a cooperative relationship is established between SRAX and its customers. Consumers who sell access to their digital data receive compensation with points that they can redeem for cash or gift cards. At the same time, BIGtoken is able to provide verified, high-quality data to advertisers that pay a premium to access consumer-corroborated information for their campaigns. SRAX does not sell BIGtoken data directly to advertisers; it sells access to the data, in the form of anonymized segments.

Along with BIGtoken, SRAX’s product family includes SRAX IR, SRAX Shopper, SRAX Core and SRAX Lux. SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. SRAX Shopper delivers a cross-channel, premium digital experience at scale to high-value shopper audiences. SRAX Core offers one complete dashboard to manage digital media campaigns, inventory and reporting. SRAX Lux targets and reaches luxury consumers at luxury retail stores and high-end art galleries, as well as music, film, fashion and sports events.

SRAX is committed to its mission of delivering tools to unlock the value of data, benefitting consumers and advertisers alike. Significant for investors is that through monetizing its data sets, SRAX is growing numerous, recurring revenue streams by way of its different platforms. SRAX is offering everyone in the internet ecosystem choice, transparency and compensation – coupled with a commitment to privacy and data ownership.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, December 20th, 2019 Uncategorized Comments Off on $SRAX Focusing on Privacy, Data Ownership as It Builds Valuable Opt-In Consumer Data Set

$GWPD GrowPods May Help Reduce Foodborne Illnesses

GP Solutions (OTC: GWPD), the developer of modular automated micro-farms, on Wednesday announced that GrowPods may help reduce foodborne illnesses. The update highlighted food grown in Controlled Environment Micro-Farms, such as GrowPods, as a way of providing automated cultivation of clean, uncontaminated vegetables, herbs and leafy greens, and included quotations from various publications and others outlining the benefits of farming in controlled environments. “Inside a GrowPod, the air and water are filtered, and since it is a sealed environment, there is little chance for contamination,” according to Business Management News.

To view the full press release, visit http://nnw.fm/f0oLw

About GP Solutions, Inc.

GP Solutions, Inc. is the developer of highly innovative automated micro-farms trade named “GrowPods.” GrowPods are a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. Offering fully insulated, food-grade shipping container that has been specifically modified to provide the optimum controlled environment for growing a wide range of horticultural and agricultural products in all environments and climates. With the company’s combination of hydroponic and certified organic soil systems, clients can produce a significantly higher yield that grows faster, healthier and more consistent. For more information, visit the company’s website at www.GrowPodSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to GWPD are available in the company’s newsroom at http://nnw.fm/GWPD

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, December 19th, 2019 Uncategorized Comments Off on $GWPD GrowPods May Help Reduce Foodborne Illnesses

$LXRP Business Leaders Say Federal Hemp Rules Could Hamper the Smokable Flower Market

December 19, 2019

Just a year after the 2018 Farm Bill legalized the industrial use of hemp and its extracts, the market for cannabidiol (CBD), one of hemp’s main extracts, had grown so rapidly it had quickly outpaced regulatory authorities. After months of pressure from stakeholders and politicians, the United States Department of Agriculture (USDA) released its interim final rule on hemp.

However, as the sector adjusts to the new regulations, there have been fears that they may be a little too tough, especially on the budding smokable hemp industry. Observers and farmers alike fear that the USDA’s insistence on testing the topmost part of the plant, the flower, for THC concentration will leave a large number of farmers counting huge losses.

Ryan Pettigrew, a hemp consultant based in Fort Collins, Colorado, concurs. “They basically killed the smokable hemp flower market in this country when it was really starting to build steam, and it presented no rational positive concern besides the typical government fear-mongering, ‘Reefer Madness’ nonsense,” he argues.

The new regulations require all hemp plants to be tested by federal, state or otherwise approved agents in U.S. Drug Enforcement Administration (DEA) registered labs 15 days before harvest. The agents will test one plant per acre from the top 8-10 inches of the plant.

The topmost part of the plant, coincidentally, contains the highest concentrations of CBD and THC, and farmers argue this could make most of their crop test above the legal limit.

Casey Flippo, CEO, and co-founder of extraction firm Natvana in Little Rock, Arkansas says that with the new regulations, there will be zero plants grown to maturity. “It’s almost impossible until the genetics catch up to the market. There are some genetics out there that are currently being developed for little to no THC, and those are going to be an absolute necessity moving forward.”

He argues that the sampling protocol laid out by the USDA will “annihilate the market” for smokable hemp.

The USDA granted a comment period for interested parties to offer suggestions before the regulations became permanent. A lot of the commenters have proposed another sampling procedure; test the entire plant to get a more realistic expression of THC across the entire plant.

Scott Propheter, vice president of Agronomy and Outreach at Criticality, a vertically integrated hemp and CBD company in North Carolina, says that there’s a deep lack of understanding about the many variables involved in growing hemp.

“We know that farmers will be negatively impacted if the USDA rules go into place as is because right now, nobody knows enough about the genetics. Then you throw all sorts of other uncertainties into the mix, with weather, soil types, microclimates, and there are a million different variables that we just don’t know enough about.”

Industry watchers are certain that hemp companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) are watching keenly to hear how the USDA responds to these concerns since the future of the industry is at stake.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

Thursday, December 19th, 2019 Uncategorized Comments Off on $LXRP Business Leaders Say Federal Hemp Rules Could Hamper the Smokable Flower Market